FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3026143669> ?p ?o ?g. }

• W3026143669 endingPage "83" @default.
• W3026143669 startingPage "73" @default.
• W3026143669 abstract "Many patients experience recurrence of prostate cancer after radical prostatectomy.The aim of this study was to visually analyze typical patterns of lymph node (LN) involvement for prostate cancer (PC) patients with biochemical recurrence after radical prostatectomy and lymphadenectomy by creating a color-coded heat map using gallium-68 prostate-specific membrane antigen positron emission tomography (68Ga-PSMA-PET) imaging. Further, we evaluated which LNs were covered by the Radiation Therapy Oncology Group (RTOG) clinical target volume (CTV) contouring guidelines.A total of 1653 68Ga-PSMA-PET/computed tomography (CT) datasets were screened retrospectively. After meeting the eligibility criteria, 233 patients with 799 LN metastases were included in our study.We created a comprehensive three-dimensional color-coded LN atlas. Further, the coverage of LN metastases by RTOG CTV was assessed and stratification for risk factors was performed.In the overall, mainly high risk, collective, complete coverage by the standard RTOG CTV was accomplished in 31.0% of all LN metastases. The vast majority of uncovered LNs are situated in the para-aortal, pararectal, paravesical, preacetabular, presacral, and inguinal regions. Concerning examined stratification factors, prostate-specific antigen (PSA) levels at the time of PET/CT imaging had the highest predictive value for extrapelvic metastatic LN spread. Every increase of 1 ng/mL in PSA raises the risk of metastases outside the CTV by a factor of 1.43.We developed the first LN atlas for patients with recurrent PC using a heat map technique, in order to illustrate hot spots of LN recurrence. The vast majority of detected LNs are not covered by a standard CTV as recommended by the RTOG. Application of the standard RTOG CTV for pelvic irradiation in the salvage setting for high-risk PC patients seems to be inappropriate.We visualized typical lymph node recurrence sites for patients after prostate cancer surgery." @default.
• W3026143669 created "2020-05-29" @default.
• W3026143669 creator A5002762582 @default.
• W3026143669 creator A5027036343 @default.
• W3026143669 creator A5035239300 @default.
• W3026143669 creator A5038906134 @default.
• W3026143669 creator A5044900037 @default.
• W3026143669 creator A5053829502 @default.
• W3026143669 creator A5057421384 @default.
• W3026143669 creator A5061037633 @default.
• W3026143669 creator A5067456208 @default.
• W3026143669 creator A5067838462 @default.
• W3026143669 creator A5067941796 @default.
• W3026143669 creator A5081479868 @default.
• W3026143669 creator A5083070882 @default.
• W3026143669 date "2021-02-01" @default.
• W3026143669 modified "2023-10-17" @default.
• W3026143669 title "PSMA-PET/CT–based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy" @default.
• W3026143669 cites W1757407923 @default.
• W3026143669 cites W1965408806 @default.
• W3026143669 cites W2000979583 @default.
• W3026143669 cites W2014999922 @default.
• W3026143669 cites W2024821597 @default.
• W3026143669 cites W2080957338 @default.
• W3026143669 cites W2117792530 @default.
• W3026143669 cites W2125363072 @default.
• W3026143669 cites W2131034864 @default.
• W3026143669 cites W2137670219 @default.
• W3026143669 cites W2149696900 @default.
• W3026143669 cites W2169597383 @default.
• W3026143669 cites W2211198407 @default.
• W3026143669 cites W2234163738 @default.
• W3026143669 cites W2252550361 @default.
• W3026143669 cites W2269266605 @default.
• W3026143669 cites W2295059387 @default.
• W3026143669 cites W2299477037 @default.
• W3026143669 cites W2340422569 @default.
• W3026143669 cites W2470255787 @default.
• W3026143669 cites W2487033212 @default.
• W3026143669 cites W2508622292 @default.
• W3026143669 cites W2510755861 @default.
• W3026143669 cites W2511949746 @default.
• W3026143669 cites W2642623263 @default.
• W3026143669 cites W2792798170 @default.
• W3026143669 cites W2885222790 @default.
• W3026143669 cites W2898544959 @default.
• W3026143669 cites W2910056648 @default.
• W3026143669 cites W2923367097 @default.
• W3026143669 doi "https://doi.org/10.1016/j.euo.2020.04.004" @default.
• W3026143669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32451312" @default.
• W3026143669 hasPublicationYear "2021" @default.
• W3026143669 type Work @default.
• W3026143669 sameAs 3026143669 @default.
• W3026143669 citedByCount "28" @default.
• W3026143669 countsByYear W30261436692021 @default.
• W3026143669 countsByYear W30261436692022 @default.
• W3026143669 countsByYear W30261436692023 @default.
• W3026143669 crossrefType "journal-article" @default.
• W3026143669 hasAuthorship W3026143669A5002762582 @default.
• W3026143669 hasAuthorship W3026143669A5027036343 @default.
• W3026143669 hasAuthorship W3026143669A5035239300 @default.
• W3026143669 hasAuthorship W3026143669A5038906134 @default.
• W3026143669 hasAuthorship W3026143669A5044900037 @default.
• W3026143669 hasAuthorship W3026143669A5053829502 @default.
• W3026143669 hasAuthorship W3026143669A5057421384 @default.
• W3026143669 hasAuthorship W3026143669A5061037633 @default.
• W3026143669 hasAuthorship W3026143669A5067456208 @default.
• W3026143669 hasAuthorship W3026143669A5067838462 @default.
• W3026143669 hasAuthorship W3026143669A5067941796 @default.
• W3026143669 hasAuthorship W3026143669A5081479868 @default.
• W3026143669 hasAuthorship W3026143669A5083070882 @default.
• W3026143669 hasConcept C121608353 @default.
• W3026143669 hasConcept C126322002 @default.
• W3026143669 hasConcept C126838900 @default.
• W3026143669 hasConcept C127413603 @default.
• W3026143669 hasConcept C199639397 @default.
• W3026143669 hasConcept C2775842073 @default.
• W3026143669 hasConcept C2776235491 @default.
• W3026143669 hasConcept C2777008409 @default.
• W3026143669 hasConcept C2779104521 @default.
• W3026143669 hasConcept C2779466945 @default.
• W3026143669 hasConcept C2780192828 @default.
• W3026143669 hasConcept C2780824555 @default.
• W3026143669 hasConcept C2780849966 @default.
• W3026143669 hasConcept C2781406297 @default.
• W3026143669 hasConcept C2989005 @default.
• W3026143669 hasConcept C509974204 @default.
• W3026143669 hasConcept C71924100 @default.
• W3026143669 hasConceptScore W3026143669C121608353 @default.
• W3026143669 hasConceptScore W3026143669C126322002 @default.
• W3026143669 hasConceptScore W3026143669C126838900 @default.
• W3026143669 hasConceptScore W3026143669C127413603 @default.
• W3026143669 hasConceptScore W3026143669C199639397 @default.
• W3026143669 hasConceptScore W3026143669C2775842073 @default.
• W3026143669 hasConceptScore W3026143669C2776235491 @default.
• W3026143669 hasConceptScore W3026143669C2777008409 @default.
• W3026143669 hasConceptScore W3026143669C2779104521 @default.
• W3026143669 hasConceptScore W3026143669C2779466945 @default.

• next